| Consenters |  |  | P | |||
---|---|---|---|---|---|---|---|
Usual care | Intervention | Decliners | |||||
(N = 166) | (N = 165) | (N = 115) | |||||
n | % | n | % | n | % | ||
Oncology facility | Â | Â | Â | Â | Â | Â | 0.02 |
 Site 1 | 70 | 42.2 | 70 | 42.4 | 64 | 55.7 |  |
 Site 2 | 96 | 57.8 | 95 | 57.6 | 51 | 44.3 |  |
Age at baseline, years | Â | Â | Â | Â | Â | Â | 0.30 |
 Mean | 67.6 | 67.2 | 68.1 |  | |||
 Standard Deviation | 6.7 | 6.9 | 7.9 |  | |||
Range | 46–85 | 51–84 | 44–82 |  | |||
 <65 | 54 | 32.5 | 56 | 33.9 | 32 | 27.8 |  |
 ≥65 | 112 | 67.5 | 109 | 66.1 | 83 | 72.2 |  |
Marital status | |||||||
 Married/defacto | 136 | 81.9 | 127 | 77.0 |  |  |  |
 Other | 30 | 18.1 | 38 | 23.0 |  |  |  |
Location | Â | Â | Â | Â | Â | Â | 0.14 |
 Urban | 136 | 81.9 | 136 | 82.4 | 101 | 87.8 |  |
 Rural | 30 | 18.1 | 29 | 17.6 | 13 | 11.3 |  |
 Missing |  |  |  |  | 1 |  |  |
Risk group (D’Amico, 1998) |  |  |  |  |  |  | 0.16 |
 Low | 11 | 10.6 | 11 | 11.6 | 4 | 3.9 |  |
 Intermediate | 44 | 42.3 | 39 | 41.1 | 37 | 35.9 |  |
 High | 49 | 47.1 | 45 | 47.4 | 38 | 36.9 |  |
Scheduled treatment | Â | Â | Â | Â | Â | Â | 0.29 |
 Salvage EBRT | 61 | 36.7 | 69 | 41.8 | 31 | 27.0 |  |
 Brachytherapy followed by EBRT | 8 | 4.8 | 9 | 5.5 | 8 | 7.0 |  |
 EBRT followed by brachytherapy | 5 | 3.0 | 3 | 1.8 | 1 | 0.9 |  |
 EBRT alone | 92 | 55.4 | 84 | 50.9 | 70 | 60.9 |  |
Previous treatment | |||||||
 Any previous treatment |  |  |  |  |  |  | 0.60 |
  No | 39 | 23.5 | 34 | 20.6 | 28 | 24.3 |  |
  Yes | 127 | 76.5 | 131 | 79.4 | 87 | 75.7 |  |
 Active surveillance |  |  |  |  |  |  | 1.00 |
  No | 148 | 89.2 | 153 | 92.7 | 105 | 91.3 |  |
  Yes | 18 | 10.8 | 12 | 7.3 | 10 | 8.7 |  |
 Prostatectomy |  |  |  |  |  |  | 0.15 |
  No | 105 | 63.3 | 96 | 58.2 | 79 | 68.7 |  |
  Yes | 61 | 36.7 | 69 | 41.8 | 36 | 31.3 |  |
 Androgen deprivation |  |  |  |  |  |  | 0.49 |
  No | 113 | 68.1 | 116 | 70.3 | 75 | 65.2 |  |
  Yes | 53 | 31.9 | 49 | 29.7 | 40 | 34.8 |  |